ReviewLeukemia2025

The evolving landscape of epigenetic target molecules and therapies in myeloid cancers: focus on acute myeloid leukemia and myeloproliferative neoplasms.

Michael W M Kühn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.